{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:51:16Z","timestamp":1793361076865,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001949.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000}}],"reference-count":176,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001949.pub3","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T09:39:03Z","timestamp":1383730743000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pimozide for schizophrenia or related psychoses"],"prefix":"10.1002","volume":"2013","author":[{"given":"Meghana","family":"Mothi","sequence":"first","affiliation":[{"name":"Newsam Centre, Seacroft Hospital; General Adult Psychiatry; Leeds and York NHS Foundation Trust York Road Leeds UK LS14 6WB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sampson","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health University of Nottingham Innovation Park, Jubilee Campus Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,5]]},"reference":[{"key":"10.1002\/14651858.CD001949.pub3-BIB0002|cit1","first-page":"71","article-title":"Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"13","author":"Abuzzahab","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0001|cit2","first-page":"26","article-title":"A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"12","author":"Abuzzahab","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0003|cit3","first-page":"547","article-title":"Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl","volume":"24","author":"Abuzzahab","year":"1980","journal-title":"Advances in Biochemistry and Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0004|cit4","first-page":"15","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients","volume":"13","author":"Amin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0447.1974.tb08043.x","article-title":"A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes","volume":"249","author":"Andersen","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0006|cit6","first-page":"17","article-title":"Clinical trial of pimozide","volume":"3","author":"Anumonye","year":"1976","journal-title":"West African Journal of Pharmacology and Drug Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00583530","article-title":"Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine","volume":"18","author":"Barnes","year":"1983","journal-title":"Social Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0008|cit8","unstructured":"Barnes TR Platt SD E-mail correspondence E-mail correspondence June 2011"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0009|cit9","first-page":"598","article-title":"Pimozide in the treatment of chronic schizophrenic patients","volume":"12","author":"Chouinard","year":"1970","journal-title":"Current Therapeutic Research and Clinical Experience"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00430747","article-title":"Pimozide in the treatment of newly admitted schizophrenic patients","volume":"76","author":"Chouinard","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0011|cit11","first-page":"1005","article-title":"A double blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients","volume":"16","author":"Claghorn","year":"1974","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0013|cit12","unstructured":"Clark ML Pimozide vs thioridazine vs placebo Early Clinical Drug Evaluation Unit Reports 1973"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0012|cit13","first-page":"137","article-title":"Pimozide in chronic schizophrenic outpatients","volume":"36","author":"Clark","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0014|cit14","first-page":"47","article-title":"Pimozide (orap, R 6238) in residual schizophrenia: a clinical evaluation with long-term double-blind follow-up","volume":"76","author":"Denijs","year":"1973","journal-title":"Psychiatria Neurologia Neurochirurgia"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0018|cit15","unstructured":"De Ronchi D Levosulpiride vs pimozide in negative symptoms of schizophrenia Proceedings of the Xth World Congress of Psychiatry; August 23-28, 1996; Madrid, Spain 1996"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0015|cit16","first-page":"859","article-title":"Levosulpiride vs pimozide in schizophrenic patients: efficacy and adverse events","volume":"17","author":"Ronchi","year":"1997","journal-title":"Neurologia Psichiatria Scienze Umane"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0016|cit17","doi-asserted-by":"crossref","unstructured":"De Ronchi D Ruggeri M Balelli G Volterra V Levosulpiride vs pimozide in negative symptoms of schizophrenia Proceedings of the 8th ECNP (European College of Neuropsychopharmacology) Congress; September 30-October 4, 1995; Venice, Italy 1995","DOI":"10.1016\/0924-977X(95)90546-P"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0017|cit18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0011-393X(96)80085-3","article-title":"Levosulpiride versus pimozide in negative symptoms of schizophrenia","volume":"57","author":"Ronchi","year":"1996","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0019|cit19","first-page":"119","article-title":"Pimozide versus fluphenazine in ambulatory schizophrenics: a 12-month comparison study","volume":"38","author":"Donlon","year":"1977","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0033291700006632","article-title":"A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033291700014318","article-title":"The social outcome of patients in a trial of long-term continuation therapy","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0364-7722(79)90050-X","article-title":"Medico-social evaluation of the long term pharmacotherapy of schizophrenia: comparaive study of fluphenazine and pimozide","volume":"3","author":"Shepherd","year":"1979","journal-title":"Progressive Neuro-Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/npp.2011.14","article-title":"Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy","volume":"36","author":"Friedman","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0024|cit24","first-page":"487","article-title":"Pimozide (R6238) in chronic schizophrenia: double blind trial","volume":"78","author":"Gowardman","year":"1973","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0025|cit25","first-page":"696","article-title":"A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients","volume":"16","author":"Gross-HS","year":"1974","journal-title":"Current Therapeutic Research and Clinical Experience"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0027|cit26","unstructured":"Gunduz-Bruce H Efficacy of pimozide augmentation for clozapine partial response Clinicaltrials.gov"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0026|cit27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.schres.2012.11.008","article-title":"Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia","volume":"143","author":"Gunduz-Bruce","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1019512","article-title":"Pimozide versus haloperidol in acute schizophrenia: a double blind controlled study","volume":"15","author":"Haas","year":"1982","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/009127007101100410","article-title":"Pimozide in chronic schizophrenic patients","volume":"11","author":"Huber","year":"1971","journal-title":"Journal of Clinical Pharmacology and New Drugs"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0030|cit30","first-page":"768","article-title":"Comparison of pimozide and trifluoperazine as once-daily therapy in chronic schizophrenic outpatients","volume":"21","author":"Kline","year":"1977","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0031|cit31","first-page":"998","article-title":"A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients","volume":"16","author":"Kolivakis","year":"1974","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0033|cit32","first-page":"685","article-title":"A double blind comparison of pimozide with carpipramine in schizophrenic patients","volume":"72","author":"Kudo","year":"1972","journal-title":"Acta Psychiatrica Belgica"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub3-BIB0032|cit33","first-page":"726","article-title":"The double-blind study of pimozide for schizophrenia","volume":"82","author":"Kudo","year":"1972","journal-title":"Igaku No Ayumi"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.137.6.510","article-title":"Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"137","author":"McCreadie","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.140.3.280","article-title":"Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"140","author":"McCreadie","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1192\/bjp.161.4.496","article-title":"The Scottish First Episode Schizophrenia Study. VIII. Five-year follow-up: clinical and psychosocial findings","volume":"161","author":"Scottish Schizophrenia Research Group","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0447.1989.tb03032.x","article-title":"The Scottish First Episode Schizophrenia Study. VII. Two-year follow up","volume":"80","author":"Wiles","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.150.3.334","article-title":"The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol","volume":"150","author":"The Scottish Schizophrenia Research Group","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.150.3.338","article-title":"The Scottish First Episode Schizophrenia Study. III. Cognitive performance","volume":"150","author":"The Scottish Schizophrenia Research Group","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.152.4.470","article-title":"The Scottish First Episode Schizophrenia Study: one-year follow-up","volume":"152","author":"The Scottish Schizophrenia Research Group","year":"1988","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0041|cit41","first-page":"170","article-title":"The observer interaction variable in evaluation of socialising properties of pimozide (Orap)","volume":"87","author":"McInnes","year":"1978","journal-title":"New Zealand Medicine Journal"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0006-3223(85)90174-X","article-title":"Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers","volume":"20","author":"Nishikawa","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/070674378202700305","article-title":"Comparison of pimozide and chlorpromazine in acute schizophrenia","volume":"27","author":"Pecknold","year":"1982","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0044|cit44","unstructured":"Pinard G Prenoveau Y Fielsen W Elie R Bielman P Lamontagne Y Proceedings of the World Congress of Psychiatry, 28 November-4 December 1971; Ciudad de Mexico 1971"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0045|cit45","first-page":"22","article-title":"Pimozide: a comparative study in the treatment of chronic schizophrenic patients","volume":"6","author":"Pinard","year":"1972","journal-title":"International Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-3956(84)90016-5","article-title":"The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol","volume":"18","author":"Silverstone","year":"1984","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0047|cit47","first-page":"17","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients","volume":"13","author":"Vergara","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0048|cit48","first-page":"62","article-title":"Pimozide versus chlorpromazine in chronic schizophrenia, a 52-week double-blind study of maintenance therapy","volume":"43","author":"Wilson","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub3-BIB0049|cit49","first-page":"189","article-title":"Pimozide (R6238): clinical tests with a new incisive neuroleptic of long lasting action","volume":"4","author":"Baggio","year":"1970","journal-title":"Revista Brasileira Psiquiatrica"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0050|cit50","first-page":"199","article-title":"Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment\uff0da multidisciplinary approach","volume":"72","author":"Baro","year":"1972","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0051|cit51","first-page":"137","article-title":"No English title available","volume":"68","author":"Bobon","year":"1968","journal-title":"Acta Neurologica Belgiana"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0052|cit52","first-page":"888","article-title":"No English title available","volume":"68","author":"DP","year":"1968","journal-title":"Acta Neurologica Belgiana"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0053|cit53","first-page":"875","article-title":"A multicentric clinical evaluation of pimozide: preliminary report","volume":"68","author":"Brugmans","year":"1968","journal-title":"Acta Neurologica Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/j.1552-4604.1972.tb00032.x","article-title":"An international double-blind clinical evaluation of pimozide","volume":"12","author":"Janssen","year":"1972","journal-title":"Journal Clinical Pharmacology and New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"s325","DOI":"10.1016\/S0924-977X(00)80395-8","article-title":"Risperidone versus pimozide for the treatment of monosymptomatic hypochondriacal psychosis","volume":"10","author":"Cetin","year":"2000","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1185\/03007997909109396","article-title":"Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics","volume":"6","author":"Cheadle","year":"1979","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0057|cit57","unstructured":"Chouinard G Annabel L Lafontaine HL Pimozide in the treatment of acute schizophrenia Proceedings of the 132nd Annual Meeting of the American Psychiatric Association; 1979 May 12-18; Chicago, Illinois, USA 1979"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0058|cit58","first-page":"35","article-title":"Pimozide versus placebo","volume":"7","author":"Clark","year":"1971","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"II. A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0060|cit60","unstructured":"Johnstone EC Owens DGC Does early treatment have an effect on outcome? Proceedings of the 10th European College of Neuropharmacology Congress; September 13-17, 1997; Vienna, Austria 1997"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.148.2.128","article-title":"III. Short-term outcome in trial entrants and trial eligible patients","volume":"148","author":"MacMillan","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0447.1974.tb08045.x","article-title":"Objective evaluation of EEG amplitude in chronic schizophrenic patients during a controlled trial of pimozide and trifluoperazine","volume":"249","author":"d'Elia","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0063|cit63","first-page":"235","article-title":"Pimozide treatment of the negative schizophrenic syndrome: an open trial","volume":"49","author":"Feinberg","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0006-3223(97)00227-8","article-title":"Pimozide augmentation for the treatment of schizophrenic patients who are trial responders to clozapine","volume":"42","author":"Friedman","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0065|cit65","first-page":"389","article-title":"No English title available","volume":"96","author":"Frussa Filho","year":"1988","journal-title":"Farmacologia Clinica"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1185\/03007997909109017","article-title":"Pimozide in acute schizophrenia: a pilot study","volume":"5","author":"Garton","year":"1979","journal-title":"Current Medical Research Opinion"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0067|cit67","first-page":"83","article-title":"No English title available","volume":"22","author":"Gomez Perez","year":"1994","journal-title":"Actas Luso-Espanol Neurologia Psiquiatria"},{"issue":"8","key":"10.1002\/14651858.CD001949.pub3-BIB0068|cit68","first-page":"888","article-title":"Pimozide and haloperidol in a double-blind study in acutely schizophrenic patients","volume":"32","author":"Haas","year":"1982","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0069|cit69","first-page":"138","article-title":"Nebenwirkungen von neuroleptika","volume":"11","author":"Holl","year":"1992","journal-title":"Nervenheeikunde"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0070|cit70","first-page":"604","article-title":"Long-term treatment of schizophrenia","volume":"78","author":"Huber","year":"1983","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0071|cit71","unstructured":"Ibarra HS Concha SJ Coronel AR Cruz PR Alarcon NA Pimozide in the treatment of delusional disorder Proceedings of the 10th World Congress of Psychiatry; 1996 Aug 23-28; Madrid, Spain 1996"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(88)90682-4","article-title":"The Northwick park \"functional\" psychosis study: diagnosis and treatment response","volume":"2","author":"Johnstone","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0073|cit73","first-page":"69","article-title":"Pimozide compared with fluphenazine in schizophrenia","volume":"25","author":"Kenway","year":"1971","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0074|cit74","first-page":"67","article-title":"A double-blind comparison of pimozide and haloperidol in the treatment of recurrent anxiety states","volume":"27","author":"Kenway","year":"1973","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0075|cit75","first-page":"359","article-title":"No English title available","volume":"23","author":"Konig","year":"1971","journal-title":"Psychiatry Neurology Medicine and Psychology"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0733-8635(05)70379-X","article-title":"Psychopharmacology for dermatologic patients","volume":"14","author":"Koo","year":"1996","journal-title":"Dermatologic Clinics"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0077|cit77","first-page":"68","article-title":"Pimozide versus standards versus placebo","volume":"7","author":"Krumholz","year":"1970","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0078|cit78","first-page":"8","article-title":"A controlled pimozide, fluphenazine and group psychotherapy study of chronic schizophrenics","volume":"1","author":"Lapierre","year":"1976","journal-title":"Psychiatric Journal of the University of Ottawa"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0079|cit79","first-page":"181","article-title":"Pimozide and the social behavior of schizophrenics","volume":"18","author":"Lapierre","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0080|cit80","first-page":"61","article-title":"Pimozide versus fluphenazine","volume":"7","author":"Lehmann","year":"1970","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0081|cit81","first-page":"45","article-title":"A double blind placebo controlled trial of pimozide (R6238) on 49 hospitalized chronic schizophrenics","volume":"17","author":"Mahal","year":"1975","journal-title":"Indian Journal of Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001949.pub3-BIB0082|cit82","first-page":"49","article-title":"Pimozide (Orap): a multicentre study","volume":"7","author":"Marshall","year":"1971","journal-title":"Clinical Trials Journal"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0083|cit83","first-page":"655","article-title":"Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)","volume":"10","author":"Masiak","year":"1976","journal-title":"Psychiatrica Poland"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10401239209150446","article-title":"Rapid response to pimozide in treatment resistant delusional disorder","volume":"4","author":"McCoy","year":"1992","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.133.2.179","article-title":"Token economy, pimozide and chronic schizophrenia","volume":"133","author":"McCreadie","year":"1978","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/S0007125000116691","article-title":"Weekly pimozide versus fluphenazine decanoate in schizophrenic out- and day-patients","volume":"143","author":"McCreadie","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ddr.430090105","article-title":"Novel approaches to the pharmacotherapy of schizophrenia","volume":"9","author":"Meltzer","year":"1986","journal-title":"Drug Development Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02244775","article-title":"Negative symptoms in schizophrenia: considerations for clinical trials: working group on negative symptoms in schizophrenia","volume":"115","author":"Moller","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1192\/bjp.117.541.683","article-title":"A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia","volume":"117","author":"Morris","year":"1970","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/01454455970213004","article-title":"A review of cognitive behavioral and pharmacological treatment of body dysmorphic disorder","volume":"21","author":"Neziroglu","year":"1997","journal-title":"Behavioral Modification"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0010-440X(94)90165-1","article-title":"Psychopharmacologic treatment of negative symptoms","volume":"35","author":"LA","year":"1994","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0193-953X(18)30061-3","article-title":"Pharmacologic treatment of delusions","volume":"18","author":"Opler","year":"1995","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub3-BIB0093|cit93","first-page":"597","article-title":"Pharmacologic treatment of body dysmorphic disorder","volume":"32","author":"Phillips","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0920-9964(96)00067-9","article-title":"Lack of gender differences in neuroleptic response in patients with schizophrenia","volume":"22","author":"Pinals","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000468208","article-title":"Application of the neuroleptic pimozide (ORAP-R6238) for tranquillizer indications in a controlled study","volume":"11","author":"Poldinger","year":"1976","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1185\/03007997209111154","article-title":"A comative double-blind trial of pimozide in stress-induced psychic and functional disorders","volume":"1","author":"Reyntjens","year":"1972","journal-title":"Current Medical Research Opinion"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub3-BIB0097|cit97","first-page":"247","article-title":"A clinical study with pimozide in chronic schizophrenics","volume":"12","author":"Ruiz Ruiz","year":"1975","journal-title":"Revista de Psiquiatria y Psicologia Medica de Europa y America Latinas"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0033291700056415","article-title":"Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial","volume":"5","author":"Sims","year":"1975","journal-title":"Psychological Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub3-BIB0099|cit99","first-page":"695","article-title":"Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients","volume":"13","author":"Singh","year":"1971","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3956(74)90073-9","article-title":"A pilot study of pimozide in schizophrenia","volume":"11","author":"Smythies","year":"1974","journal-title":"Journal of Psychiatric Research"},{"issue":"12","key":"10.1002\/14651858.CD001949.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-4362.1994.tb01019.x","article-title":"Nature and treatment of delusional parasitosis: a different experience in India","volume":"33","author":"Srinivasan","year":"1994","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub3-BIB0102|cit102","first-page":"1107","article-title":"The clinical efficacy of pimozide in chronic psychotic patients","volume":"5","author":"Sterkmans","year":"1968","journal-title":"Clinical Trials Journal"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub3-BIB0103|cit103","first-page":"706","article-title":"A pilot study of pimozide in chronic schizophrenic patients","volume":"13","author":"Sugerman","year":"1971","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0104|cit104","first-page":"93","article-title":"A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses","volume":"14","author":"Svestka","year":"1972","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-1002227","article-title":"Therapeutische manahmen bei spaten extrapyramidalen hyperkineson","volume":"51","author":"Tegeler","year":"1983","journal-title":"Fortschr Neurology Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00007611-199303000-00019","article-title":"Clinical uses of pimozide","volume":"86","author":"Teuth","year":"1993","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0107|cit107","first-page":"103","article-title":"Pimozide treatment for delusion of infestation","volume":"28","author":"Ungvari","year":"1986","journal-title":"Acta Nervosa Superior Praha"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001949.pub3-BIB0108|cit108","first-page":"33","article-title":"Profile of the action of neuroleptics in deficit schizophrenia","volume":"22","author":"Vanelle","year":"1996","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.1982.04290030011002","article-title":"Antipsychotic effects of pimozide in schizophrenia: treatment response prediction with acute dextroamphetamine response","volume":"39","author":"Kammen","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000118403","article-title":"Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?","volume":"18","author":"Kammen","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0111|cit111","first-page":"515","article-title":"Pimozide: an effective, once daily oral therapy for schizophrenia","volume":"46","author":"Wyk","year":"1972","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S0033291700048091","article-title":"The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment","volume":"13","author":"Watt","year":"1983","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0113|cit113","first-page":"113","article-title":"Differences in the clinical effects of various neuroleptics","volume":"XIV","author":"Welbel","year":"1980","journal-title":"Psychiatrica Poland"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3999\/jscpt.3.91","article-title":"A double-blind comparison of pimozide (r-6238) with chlorpromazine in chronic schizophrenia","volume":"3","author":"Umene","year":"1972","journal-title":"Rinsho Yakuri"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD001949.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia: definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials: the CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes: trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0120|cit120","unstructured":"BNF http:\/\/www.bnf.org\/bnf\/index.htm"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0121|cit121","volume-title":"British National Formulary","volume":"63","author":"Royal Pharmaceutical Society of Great Britain","year":"2012"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub3-BIB0122|cit122","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1943-278X.1992.tb01040.x","article-title":"Schizophrenia: a high-risk factor for suicide: clues to risk reduction","volume":"22","author":"Caldwell","year":"1992","journal-title":"Suicide and Life-Threatening Behavior"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0124|cit124","first-page":"233","article-title":"The Extrapyramidal Symptom Rating Scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"Suppl","key":"10.1002\/14651858.CD001949.pub3-BIB0125|cit125","first-page":"227","article-title":"Last observation carried forward in psychiatric research: a flawed gold standard?","volume":"81","author":"Cotton","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0126|cit126","first-page":"1","article-title":"Cardiotoxic effects of pimozide","volume":"29","author":"Committee on Safety of Medicines","year":"1990","journal-title":"Current Problems"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1192\/apt.bp.106.002600","article-title":"Developmental aspects of schizophrenia and related disorders: possible implications for treatment strategies","volume":"13","author":"Davies","year":"2007","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0129|cit129","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 October 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for the use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD001949.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0137|cit137","volume-title":"Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0139|cit139","article-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","volume-title":"Cochrane Library","volume":"3","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0140|cit140","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org."},{"key":"10.1002\/14651858.CD001949.pub3-BIB0141|cit141","volume-title":"ICD-10 Classification of Mental and Behavioral Disorders","author":"World Health Organisation","year":"1991"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised controlled trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0143|cit143","article-title":"Function and dysfunction of the basal ganglia","volume-title":"The Rise of Psychopharmacology and the Story of CINP","author":"Janssen","year":"1998"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0145|cit145","first-page":"487","article-title":"Other psychotic disorders","volume-title":"Synopsis of Psychiatry","author":"Kaplan","year":"1994"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2466\/pr0.1963.13.2.503","article-title":"Methods for measuring adjustment and social behaviour in the community. I. Rationale, description, discriminative validity and scale development","volume":"13","author":"Katz","year":"1963","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0147|cit147","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0149|cit149","first-page":"259","article-title":"Neuroleptics and schizophrenia","author":"King","year":"1995","journal-title":"Seminars in Clinical Psychopharmacology"},{"issue":"2-3","key":"10.1002\/14651858.CD001949.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"Montgomery Asberg Depression Rating Scale","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0157|cit157","first-page":"34","article-title":"Monosymptomatic hypochondriacal psychosis","volume":"24","author":"Munro","year":"1980","journal-title":"British Journal of Hospital Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001949.pub3-BIB0158|cit158","first-page":"221","article-title":"The role of pimozide in clinical psychiatry","volume":"52","author":"Opler","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00577960","article-title":"The Social Behaviour Assessment Schedule (SBAS): rationale, contents, scoring and reliability of a new interview schedule","volume":"15","author":"Platt","year":"1980","journal-title":"Social Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub3-BIB0161|cit161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001361","article-title":"Depot haloperidol decanoate for schizophrenia","author":"Quraishi","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1192\/apt.bp.110.008268","article-title":"Dementia in schizophrenia","volume":"18","author":"Radhakrishnan","year":"2012","journal-title":"Advances in Psychiatric Treatment"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/swra\/19.3.9","article-title":"SLOF: a behavioral rating scale for assessing the mentally ill","volume":"19","author":"Schneider","year":"1983","journal-title":"Social Work Research & Abstracts"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1994.03520020051014","article-title":"Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals","volume":"272","author":"Schulz","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0165|cit165","first-page":"408","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA 1995"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0167|cit167","volume-title":"Drug Treatment in Psychiatry","author":"Silverstone","year":"1995"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatria Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/schbul\/16.1.87","article-title":"The impact of substance abuse on the course and outcome of schizophrenia","volume":"16","author":"Turner","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0170|cit170","article-title":"Psychopharmacology in Argentina","volume-title":"The Rise of Psychopharmacology and the Story of CINP","author":"Udabe","year":"1998"},{"issue":"5","key":"10.1002\/14651858.CD001949.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0172|cit172","volume-title":"The Measurement and Classification of Symptoms","author":"Wing","year":"1974"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0010-440X(97)90001-8","article-title":"Delusional disorder (paranoia)","volume":"18","author":"Winokur","year":"1977","journal-title":"Comprehensive Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD001949.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD001949.pub3-BIB0175|cit175","article-title":"Serotonin and obsessive compulsive disorder","volume-title":"The Rise of Psychopharmacology and the Story of CINP","author":"Yaryura-Tobias","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub3-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001949.pub2","article-title":"Pimozide for schizophrenia or related psychoses","author":"Rathbone","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001949.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T13:08:28Z","timestamp":1742735308000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001949.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,5]]},"references-count":176,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001949.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,5]]}}}